Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Interim CH-4051 Data in RA Consistent with Safety/Efficacy Benefits Over Methotrexate
Go back to Needham & Company Reiterates a 'Buy' on Chelsea Therapeutics (CHTP); Interim CH-4051 Data in RA Consistent with Safety/Efficacy Benefits Over Methotrexate| Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) | Delayed: 6.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.52 | 52 Week High | $6.83 | |||
| Open | $0.62 | 52 Week Low | $3.65 | |||
| Day High | $6.52 | P/E | N/A | |||
| Day Low | $6.52 | EPS | $-0.20 | |||
| Volume | 14,460 | |||||
